Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MERIT MEDICAL SYSTEMS INCMMSI · Entity 3858 | Director | May 30, 2025 | June 03, 2025 |
| NN INCNNBR · Entity 6041 | Director | January 02, 2020 | January 06, 2020 |
| STRYKER CORPSYK · Entity 369 | Group President | December 04, 2012 | May 17, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MERIT MEDICAL SYSTEMS INC
Report date May 30, 2025 · Filed June 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, No Par ValueSEC Table I · non-derivative | IndirectDavid K. Floyd Living Trust | 4,880 |
Reported balance
After 2025-05-30 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2025-05-30 · Sale · Disposed 3,515 · Balance 4,880 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025 F2: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.87 to $94.46, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| Common Stock, No Par ValueSEC Table I · non-derivative | IndirectDavid & Lisa Floyd Family LP | 1,584 |
Reported balance
Holding disclosure · report date 2025-05-30 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,584 |
| Common Stock, No Par ValueSEC Table I · non-derivative | Direct | 8,602 |
Reported balance
Holding disclosure · report date 2025-05-30 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 8,602 |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025
F2: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.87 to $94.46, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
NN INC
Report date January 02, 2020 · Filed January 06, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 39,946 |
Reported balance
After 2020-01-02 transaction · row 1
1 source rowRow 1 · 2020-01-02 · Grant · Acquired 16,286 · Balance 39,946 F1: Shares are restricted stock and vest on January 2, 2021. |
| Common StockSEC Table I · non-derivative | IndirectBy Family LP | 13,523 |
Reported balance
Holding disclosure · report date 2020-01-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 13,523 F2: Shares are held by the David and Lisa Floyd Family Limited Partnership of which the reporting person and his wife are the sole general partners and sole limited partners. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares are restricted stock and vest on January 2, 2021.
F2: Shares are held by the David and Lisa Floyd Family Limited Partnership of which the reporting person and his wife are the sole general partners and sole limited partners.
STRYKER CORP
Report date December 04, 2012 · Filed May 17, 2018 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2012-12-04 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance 0 F1: One line in the original filing is restated to gain access to the filing system. None of the information in the body of the original filing is being amended via this amendment. The Form 3 is amended solely to add the reporting person's power of attorney, which was omitted from the original filing and is attached hereto as Exhibit 24. |
Filing footnotes · ownership attribution and instrument terms
F1: One line in the original filing is restated to gain access to the filing system. None of the information in the body of the original filing is being amended via this amendment. The Form 3 is amended solely to add the reporting person's power of attorney, which was omitted from the original filing and is attached hereto as Exhibit 24.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 30, 2025 Filed Jun 3, 2025 21:44 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | SaleCommon Stock, No Par Value | 3,515 | $94.16 | $330,972.40 |
DisclosureSEC source: 0001415889-25-015450 · form4-06032025_090642.xml · nonDerivative · entry 2 Floyd David · CIK 0001564203 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · David K. Floyd Living Trust Disclosed balance after: 4,880 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025 F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.87 to $94.46, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 15, 2025 Filed May 19, 2025 22:44 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantCommon Stock, No Par Value | 2,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-013709 · form4-05192025_100517.xml · nonDerivative · entry 3 Floyd David · CIK 0001564203 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,033 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,152 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 15, 2026. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. Read SEC document |
| May 15, 2025 Filed May 19, 2025 22:42 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantCommon Stock, No Par Value | 2,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-013706 · form4-05192025_100515.xml · nonDerivative · entry 3 Floyd David · CIK 0001564203 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,033 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,152 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 15, 2026. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. Read SEC document |
| May 16, 2024 Filed May 20, 2024 21:49 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantCommon Stock, No Par Value | 2,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-013812 · form4-05202024_090557.xml · nonDerivative · entry 3 Floyd David · CIK 0001564203 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,881 F2 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,431 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 16, 2025. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. F1 · balance_after: Reflects a transfer of 3,050 shares on June 8, 2023 held directly by the reporting person to the David K. Floyd Living Trust in a transaction exempt from reporting under Rule 16a-13. Read SEC document |
| May 18, 2023 Filed May 22, 2023 23:08 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantCommon Stock, No Par Value | 2,262 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-008544 · form4-05222023_110525.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,500 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,262 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 18, 2024. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. F2 · balance_after: Reflects a transfer of 2,914 shares on July 12, 2022 held directly by the reporting person to the David & Lisa Floyd Family LP in a transaction exempt from reporting under Rule 16a-13. Read SEC document |
| May 18, 2023 Filed May 23, 2023 22:47 UTC Amendment | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantCommon Stock, No Par Value | 2,262 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-008662 · form4a-05232023_100541.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,500 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 2,262 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 18, 2024. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. F2 · balance_after: This line in the Form 4, as originally filed on May 22, 2023, incorrectly reported a transfer of 2,914 shares on July 12, 2022 held directly by the reporting person to the David & Lisa Floyd Family LP in a transaction exempt from reporting under Rule 16a-13. This amended Form 4 solely corrects the error, reporting the transfer of 2,914 shares held directly by the reporting person to the David K. Floyd Living Trust in a transaction exempt from reporting under Rule 16a-13. Read SEC document |
| May 24, 2022 Filed May 26, 2022 22:35 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantCommon Stock, No Par Value | 3,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005724 · form4-05262022_030501.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,152 F1 · shares: The reported transaction involved the reporting person's receipt of a grant of 3,050 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 24, 2023. Vesting of the RSUs is subject to continued service to the issuer through the vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 23:12 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantCommon Stock, No Par Value | 2,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003137 · form4-06212021_040638.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,102 F1 · balance_after: The reported transaction involved the reporting person's receipt of a grant of 2,914 restricted stock units under the Merit Medical System, Inc. 2018 Long-Term Incentive Plan. The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 of Table I includes the 2,914 newly awarded restricted stock units that vest on June 17, 2022 and 4,188 previously reported time-vesting restricted stock units that vest on June 22, 2021. Vesting of restricted stock units is subject to continued service to the issuer through the vesting date. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 19:25 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | PurchaseCommon Stock, No Par Value | 1,159 | $43.11 | $49,967.39 |
DisclosureSEC source: 0001415889-20-002052 · form4-08062020_120849.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · David & Lisa Floyd Family LP Disclosed balance after: 1,584 Read SEC document |
| June 22, 2020 Filed Jun 25, 2020 00:41 UTC | MERIT MEDICAL SYSTEMS INC MMSI · Entity 3858 | GrantRestricted Stock Unit · Derivative | 4,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-001691 · form4-06242020_050621.xml · derivative · entry 2 Floyd David · CIK 0001564203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,188 Underlying: Common Stock · 4,188 shares Expires 2021-06-22 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. F2 · derivative.exercise_date: Each restricted stock unit vests on June 22, 2021 subject to continued service to the Issuer through the vesting date. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:07 UTC | NN INC NNBR · Entity 6041 | GrantCommon Stock | 16,286 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-000506 · doc4.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,946 F1 · kind: Shares are restricted stock and vest on January 2, 2021. Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:05 UTC | NN INC NNBR · Entity 6041 | PurchaseCommon Stock | 9,000 | $8.05 | $72,450.00 |
DisclosureSEC source: 0000899243-19-015151 · doc4.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family LP Disclosed balance after: 13,523 F1 · ownership.nature: Shares are held by the David and Lisa Floyd Family Limited Partnership of which the reporting person and his wife are the sole general partners and sole limited partners. Read SEC document |
| March 14, 2019 Filed Mar 19, 2019 00:24 UTC | NN INC NNBR · Entity 6041 | GrantCommon Stock | 12,610 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-008253 · doc4.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,660 F1 · kind: Shares are restricted stock and vest on March 14, 2020. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:05 UTC | NN INC NNBR · Entity 6041 | PurchaseCommon Stock | 1,200 | $16.07 | $19,284.00 |
DisclosureSEC source: 0000899243-18-024520 · doc4.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family LP Disclosed balance after: 4,523 F1 · ownership.nature: Shares are held by the David and Lisa Floyd Family Limited Partnership of which the reporting person and his wife are the sole general partners and sole limited partners. Read SEC document |
| May 01, 2018 Filed May 4, 2018 00:10 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionRestricted Stock Units granted 5/1/2015 · Derivative | 723 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000310764-18-000135 · wf-form4_152539264097341.xml · derivative · entry 5 Floyd David · CIK 0001564203 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 723 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On May 1, 2018, 723 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F1 · derivative.expiration_date: On May 1, 2018, 723 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. Read SEC document |
| May 01, 2018 Filed May 4, 2018 00:10 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 352 | $169.42 | $59,635.84 |
DisclosureSEC source: 0000310764-18-000135 · wf-form4_152539264097341.xml · nonDerivative · entry 2 Floyd David · CIK 0001564203 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,214 Read SEC document |
| May 01, 2018 Filed May 4, 2018 00:10 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 723 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-18-000135 · wf-form4_152539264097341.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On May 1, 2018, 723 Restricted Stock Units vested and were settled for an equal number of shares of Stryker Common Stock. F2 · balance_after: Includes 687 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of March 31, 2018, the date of the latest available statement of the reporting person's ESPP holdings. Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 19:56 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 10,502 | $166.51 | $1,748,688.02 |
DisclosureSEC source: 0000310764-18-000083 · wf-form4_152183495283433.xml · nonDerivative · entry 2 Floyd David · CIK 0001564203 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,808 Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 19:56 UTC | STRYKER CORP SYK · Entity 369 | GrantCommon Stock | 21,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000310764-18-000083 · wf-form4_152183495283433.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,310 F1 · shares: Shares issued upon vesting of Performance Stock Units, and related dividend equivalents, that were earned based on the achievement of pre-established three-year average adjusted diluted net earnings per share goals and sales performance goals. F1 · price: Shares issued upon vesting of Performance Stock Units, and related dividend equivalents, that were earned based on the achievement of pre-established three-year average adjusted diluted net earnings per share goals and sales performance goals. F2 · balance_after: Includes 652 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2017, the date of the latest available statement of the reporting person's ESPP holdings. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 21:42 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 02/08/2017 (right to buy) · Derivative | 11,020 | $122.51 Strike: $122.51 | $1,350,060.20 |
DisclosureSEC source: 0000310764-18-000062 · wf-form4_152149569823031.xml · derivative · entry 15 Floyd David · CIK 0001564203 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,080 Underlying: Common Stock · 11,020 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 21:42 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 02/10/2016 (right to buy) · Derivative | 12,935 | $96.64 Strike: $96.64 | $1,250,038.40 |
DisclosureSEC source: 0000310764-18-000062 · wf-form4_152149569823031.xml · derivative · entry 14 Floyd David · CIK 0001564203 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,805 Underlying: Common Stock · 12,935 shares Expires 2026-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 21:42 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 02/11/2015 (right to buy) · Derivative | 8,382 | $93.06 Strike: $93.06 | $780,028.92 |
DisclosureSEC source: 0000310764-18-000062 · wf-form4_152149569823031.xml · derivative · entry 13 Floyd David · CIK 0001564203 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,764 Underlying: Common Stock · 8,382 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 21:42 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 02/12/2014 (right to buy) · Derivative | 7,888 | $81.14 Strike: $81.14 | $640,032.32 |
DisclosureSEC source: 0000310764-18-000062 · wf-form4_152149569823031.xml · derivative · entry 12 Floyd David · CIK 0001564203 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,888 Underlying: Common Stock · 7,888 shares Expires 2024-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 21:42 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 02/13/2013 (right to buy) · Derivative | 9,374 | $64.01 Strike: $64.01 | $600,029.74 |
DisclosureSEC source: 0000310764-18-000062 · wf-form4_152149569823031.xml · derivative · entry 11 Floyd David · CIK 0001564203 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,374 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 21:42 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 12/05/2012 (right to buy) · Derivative | 5,520 | $54.35 Strike: $54.35 | $300,012.00 |
DisclosureSEC source: 0000310764-18-000062 · wf-form4_152149569823031.xml · derivative · entry 10 Floyd David · CIK 0001564203 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,520 shares Expires 2022-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 21:42 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 55,119 | $166.58 | $9,181,844.28 |
DisclosureSEC source: 0000310764-18-000062 · wf-form4_152149569823031.xml · nonDerivative · entry 7 Floyd David · CIK 0001564203 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,760 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F3 · price: Represents the average price for transactions in a range from $165.865 to $166.97. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 21:42 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 11,020 | $122.51 | $1,350,060.20 |
DisclosureSEC source: 0000310764-18-000062 · wf-form4_152149569823031.xml · nonDerivative · entry 6 Floyd David · CIK 0001564203 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 21:42 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 12,935 | $96.64 | $1,250,038.40 |
DisclosureSEC source: 0000310764-18-000062 · wf-form4_152149569823031.xml · nonDerivative · entry 5 Floyd David · CIK 0001564203 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 21:42 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 8,382 | $93.06 | $780,028.92 |
DisclosureSEC source: 0000310764-18-000062 · wf-form4_152149569823031.xml · nonDerivative · entry 4 Floyd David · CIK 0001564203 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 21:42 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 7,888 | $81.14 | $640,032.32 |
DisclosureSEC source: 0000310764-18-000062 · wf-form4_152149569823031.xml · nonDerivative · entry 3 Floyd David · CIK 0001564203 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 21:42 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 9,374 | $64.01 | $600,029.74 |
DisclosureSEC source: 0000310764-18-000062 · wf-form4_152149569823031.xml · nonDerivative · entry 2 Floyd David · CIK 0001564203 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 21:42 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 5,520 | $54.35 | $300,012.00 |
DisclosureSEC source: 0000310764-18-000062 · wf-form4_152149569823031.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F2 · balance_after: Includes 652 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2017, the date of the latest available statement of the reporting person's ESPP holdings. Read SEC document |
| March 14, 2018 Filed Mar 16, 2018 23:37 UTC | NN INC NNBR · Entity 6041 | GrantCommon Stock | 4,073 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-007807 · doc4.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,050 F1 · price: Shares are restricted stock and vest on March 14, 2019. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 17:36 UTC | STRYKER CORP SYK · Entity 369 | GrantEmployee Stock Option granted 02/07/2018 (right to buy) · Derivative | 45,415 | $0.00 Strike: $154.14 | $0.00 |
DisclosureSEC source: 0000310764-18-000037 · edgar.xml · derivative · entry 1 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,415 Underlying: Common Stock · 45,415 shares Expires 2028-02-06 F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 21:05 UTC | NN INC NNBR · Entity 6041 | PurchaseCommon Stock | 1,865 | $26.98 | $50,317.70 |
DisclosureSEC source: 0000899243-17-027948 · doc4.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family LP Disclosed balance after: 3,323 F1 · ownership.nature: Shares are held by the David and Lisa Floyd Family Limited Partnership of which the reporting person and his wife are the sole general partners and sole limited partners. Read SEC document |
| July 12, 2017 Filed Jul 15, 2017 01:00 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 19,305 | $144.56 | $2,790,730.80 |
DisclosureSEC source: 0000310764-17-000123 · edgar.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,568 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on June 7, 2017. F2 · balance_after: Includes 460 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2016, the date of the latest available statement of the reporting person's ESPP holdings. Read SEC document |
| June 05, 2017 Filed Jun 6, 2017 22:50 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 7,381 | $144.70 | $1,068,030.70 |
DisclosureSEC source: 0000310764-17-000121 · edgar.xml · nonDerivative · entry 11 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,873 Read SEC document |
| June 05, 2017 Filed Jun 6, 2017 23:01 UTC | STRYKER CORP SYK · Entity 369 | SaleCommon Stock | 7,381 | $144.70 | $1,068,030.70 |
DisclosureSEC source: 0000310764-17-000122 · edgar.xml · nonDerivative · entry 11 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,873 Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 22:50 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 2/10/2016 (right to buy) · Derivative | 12,935 | $0.00 Strike: $96.64 | $0.00 |
DisclosureSEC source: 0000310764-17-000121 · edgar.xml · derivative · entry 18 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,740 Underlying: Common Stock · 12,935 shares Expires 2026-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 22:50 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 2/11/2015 (right to buy) · Derivative | 16,764 | $0.00 Strike: $93.06 | $0.00 |
DisclosureSEC source: 0000310764-17-000121 · edgar.xml · derivative · entry 17 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,146 Underlying: Common Stock · 16,764 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 22:50 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 2/12/2014 (right to buy) · Derivative | 23,664 | $0.00 Strike: $81.14 | $0.00 |
DisclosureSEC source: 0000310764-17-000121 · edgar.xml · derivative · entry 16 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,776 Underlying: Common Stock · 23,664 shares Expires 2024-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 22:50 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 2/13/2013 (right to buy) · Derivative | 37,496 | $0.00 Strike: $64.01 | $0.00 |
DisclosureSEC source: 0000310764-17-000121 · edgar.xml · derivative · entry 15 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,374 Underlying: Common Stock · 37,496 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 22:50 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionEmployee Stock Option granted 12/5/2012 (right to buy) · Derivative | 22,080 | $0.00 Strike: $54.35 | $0.00 |
DisclosureSEC source: 0000310764-17-000121 · edgar.xml · derivative · entry 14 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,520 Underlying: Common Stock · 22,080 shares Expires 2022-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 22:50 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 10,867 | $144.70 | $1,572,454.90 |
DisclosureSEC source: 0000310764-17-000121 · edgar.xml · nonDerivative · entry 10 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,254 Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 22:50 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 12,935 | $96.64 | $1,250,038.40 |
DisclosureSEC source: 0000310764-17-000121 · edgar.xml · nonDerivative · entry 9 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 22:50 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 13,885 | $144.70 | $2,009,159.50 |
DisclosureSEC source: 0000310764-17-000121 · edgar.xml · nonDerivative · entry 8 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,186 Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 22:50 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 16,764 | $93.06 | $1,560,057.84 |
DisclosureSEC source: 0000310764-17-000121 · edgar.xml · nonDerivative · entry 7 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 22:50 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 18,660 | $144.70 | $2,700,102.00 |
DisclosureSEC source: 0000310764-17-000121 · edgar.xml · nonDerivative · entry 6 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,307 Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 22:50 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 23,664 | $81.14 | $1,920,096.96 |
DisclosureSEC source: 0000310764-17-000121 · edgar.xml · nonDerivative · entry 5 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 22:50 UTC | STRYKER CORP SYK · Entity 369 | Tax withholdingCommon Stock | 27,429 | $144.70 | $3,968,976.30 |
DisclosureSEC source: 0000310764-17-000121 · edgar.xml · nonDerivative · entry 4 Floyd David · CIK 0001564203 · Group President, Orthopaedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,303 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.